Employee Stories
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company
About Us
Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.
Luye Pharma’s Dual TAAR1/5-HT2CR Agonist LY03020 Approved for Clinical Trials in the U.S.
News
Shanghai, January 14, 2025 – Luye Pharma Group today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for LY03020, a dual TAAR1/5-HT2CR agonist intended to treat ...
January 14,2025
Luye Pharma Announces the Approval of Zepzelca® (Lurbinectedin for Injection) by China’s National Medical Products Administration for the ...
Shanghai, December 3, 2024 - Luye Pharma Group today announced that the innovative drug Zepzelca® (lurbinectedin for injection) has been approved for marketing by China’s National Medical Products Administration (NMPA) through the ...
December 03,2024
Investors
New Year, New Team, New Power
Interview with Employees of Luye Pharma UK and Functional Team Members
A Dream of Thirteen Years
Interview with Project Team Members of LY01005
Happy Life, Happy Work
Interview with Luye Pharma Malaysia Team
Historic Breakthrough, Brand New Journey
The Story of Rykindo® (LY03004) Approval in the U.S.
Learn the Best of the People around You
Yan Yameng
HR BP, Luye Pharma
What I think When I Run
Andy Siow
APAC Commercial Director, Luye Pharma (International)
To Practice with Every Opportunity
Wang Chao
Director of Engineering Department II, Shandong Luye
My Three Years with Luye US
Antonia Sacchetti
Office Manager, Luye Pharma (US)
